Former FDA chief Rob Califf on the vaccine approval process

12/04/20 • 14 min

1 Listener

The U.S. Food and Drug Administration is reviewing two emergency use authorization requests for COVID-19 vaccines, with an outside advisory committee scheduled to meet next Thursday to review data from Pfizer and its German partner BioNTech. Dan digs in with former FDA commissioner Rob Califf, who talks about the EUA process, the science and who should make the final call. Plus, Axios media reporter Sara Fischer joins to discuss the future of theatrical releases.

Previous Episode

Faces of COVID creator on telling the stories of those we've lost

America yesterday lost 2,762 people to COVID-19, per the CDC, bringing the total pandemic toll in the U.S. to 272,525. That's more than the population of Des Moines, Iowa. Or Baton Rouge, Louisiana. Or Toledo, Ohio. Dan speaks with Alex Goldstein, creator of the @FacesofCOVID Twitter account, about telling the stories behind the statistics.

Next Episode

"Problem Solvers" co-chair Rep. Gottheimer on the state of stimulus

Nearly nine months since the CARES Act became law, ensuring that an economic recession didn't become a depression, Congress is finally close to a successor bill. Dan digs into the negotiations, and what took so long, with Rep. Josh Gottheimer (D-N.J.), co-chair of the bipartisan Problem Solvers Caucus, which has taken the lead in crafting new legislation.

If you like this episode you’ll love

The Daily Show: Ears Edition

Up First from NPR

NPR News Now

What A Day

Axios Re:Cap

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size

Copy